U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07501793) titled 'Demographic Characteristics of TAK-003 Dengue Vaccine Recipients in Vietnam' on March 24.
Brief Summary: The study aims to retrospectively describe the demographic characteristics, comorbidity profiles, vaccination history and vaccination patterns of all individuals who have received at least one dose of TAK-003 (Qdenga) dengue vaccine at all VNVC centers between September 26, 2024 and September 30, 2025. The study will utilize existing data from the VNVC immunization database. No new data collection or direct participant contact will occur.
Study Start Date: March 16
Study Type: OBSERVATIONAL
Condition:
All Individuals Who Hav...